Subscribe to MDT Magazine News

Oclaro targets fiber laser expansion to become the primary merchant supplier

May 19, 2011 10:54 am | Comments

As new entrants line up to challenge IPG, Oclaro is aiming to become the primary merchant supplier of power diodes for fiber laser systems.

Elbit lands $20M electro-optics contract

May 19, 2011 10:54 am | Comments

Unspecified Asian country places major order for optical surveillance kit, but electro-optic sales decline at the Israeli defense firm.

Supply Chain Agenda 2011 Research: Supply Chain Executives Say Market and Demand Volatility are Driving Supply Chain Visibility

May 19, 2011 10:53 am | Comments

Although the general economic outlook at the start of 2011 seems positive, a significant number of the respondents to this year's survey indicate they are uncertain about market demand in 2011 and that they are therefore determined to improve visibility


Global Trade Flow Index Reveals Impact of Japan Earthquake Led to 3% Reduction in Global Trade Levels in Q1 2011

May 19, 2011 10:52 am | Comments

A recent analysis from Capgemini Consulting reveals a decline in global trade flow levels, as a direct impact of the earthquake disaster in Japan and the resulting effect on trade with major economies. The analysis also highlights continued growth in

Unilife to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London

May 19, 2011 10:51 am | Comments

YORK, Pa., May 19, 2011 /- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS ; ASX: UNS) today announced that it will be presenting at the 2011 UBS Global Specialty Pharmaceuticals Conference in London. Dr. Ramin Mojdeh, Executive Vice-President and Chief Operating Officer of...


Johnson & Johnson to Host Pharmaceuticals Business Review

May 19, 2011 10:51 am | Comments

NEW BRUNSWICK, N.J., May 19, 2011 /- Johnson & Johnson (NYSE: JNJ ) will host a review of its Pharmaceuticals business for the investment community beginning at 9:00 a.m. (Eastern Time) on Thursday, May 26, 2011 at The Heldrich Hotel, in New Brunswick, N.J. ending at approximately...


Atomic-scale Structures of Ribosome Could Help Improve Antibiotics

May 19, 2011 10:50 am | Comments

In a development that could lead to better antibiotics, scientists from several institutions including Berkeley Lab derived atomic-scale resolution structures of the cell's protein-making machine, the ribosome, at key stages of its job. The structures reveal that the ribosome's ability to...


Emails show states didn't register execution drug

May 19, 2011 10:45 am | Comments

Some of the states scrambling to import a lethal injection sedative in scarce supply failed to properly register with federal regulators before receiving the drug from overseas, according to emails released this week.The Drug Enforcement Administration was only formally notified twice last year...


TSX-listed corporate dividends and distributions declared May 19, 2011

May 19, 2011 10:45 am | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on May 19, 2011.Bonavista Energy Corporation (TSX:BNP): $0.12. Payable Jun 15. Record May 31.Enbridge Inc. (TSX:ENB): $0.49. Payable Jun 01. Record May 13.Allied Properties Real...

Astellas Announces Vice President of Sales and Marketing for U.S. Oncology Franchise

May 19, 2011 10:43 am | Comments

DEERFIELD, Ill., May 19, 2011 /- Astellas Pharma US, Inc. ("Astellas") recently hired Mark Reisenauer as vice president of sales and marketing, oncology. Reporting directly to Patrick Shea, senior vice president of marketing & sales, Reisenauer will be responsible for all U.S....


Infinity Pharma: One cancer drug advances, one ends development

May 19, 2011 10:42 am | Comments

Infinity Pharmaceuticals Inc. is launching a Phase 2 trial of its potential treatment for non-small cell lung cancer, retaspimycin HCl in combination with the approved chemotherapy drug, Taxotere, marketed by French drug maker Sanofi.


Syneron rises on smaller 1Q loss

May 19, 2011 8:45 am | Comments

Shares of cosmetic device firm Syneron Medical Ltd. climbed Thursday after the company reported a narrower first quarter loss on double-digit revenue growth.The results beat Wall Street expectations, and Syneron shares rose 80 cents, or 6.5 percent, to $13.09 in midday trading.The Israeli...

OrbusNeich's Genousâ„¢ Stent is Safe and Effective in Cases Where Prolonged Dual Antiplatelet Therapy is Not Advisable as Presented at EuroPCR 2011

May 19, 2011 8:42 am | Comments

PARIS, May 19, 2011 /- OrbusNeich announced that data from multiple clinical trials supporting the safety and efficacy of the Genous Stent in cases where prolonged dual antiplatelet therapy (DAPT) is not advisable were featured today during the HEALING Symposium titled "How to assess and...


Spaulding Clinical Honored at BizTech Conference

May 19, 2011 8:39 am | Comments

WEST BEND, Wis., May 19, 2011 /- Leading-edge Clinical Pharmacology and Cardiac Core Lab provider, Spaulding Clinical Research, LLC proudly receives the 2011 IQ (Innovation Quotient) award sponsored by the Marquette University's Graduate School of Management and BizTimes Media, a magazine...


MEDRAD Launches Second Generation Integoâ„¢ PET Infusion System

May 19, 2011 7:38 am | Comments

WARRENDALE, Pa., May 19, 2011 /- MEDRAD, INC., a business of Bayer HealthCare, has announced the launch of the next generation Intego™ PET Infusion System, which features a new design that is 38% smaller, power-driven and includes enhancements to technologist workflow.  The new...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.